These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3931402)
1. Immunofluorescent labeling of nonhuman cerebellar tissue with sera from patients with systemic cancer and paraneoplastic cerebellar degeneration. Greenlee JE; Sun M Acta Neuropathol; 1985; 67(3-4):226-9. PubMed ID: 3931402 [TBL] [Abstract][Full Text] [Related]
2. Immunoperoxidase labelling of rat brain sections with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia. Greenlee JE; Brashear HR; Herndon RM J Neuropathol Exp Neurol; 1988 Sep; 47(5):561-71. PubMed ID: 3049946 [TBL] [Abstract][Full Text] [Related]
3. Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms. Brashear HR; Greenlee JE; Jaeckle KA; Rose JW Neurology; 1989 Dec; 39(12):1605-9. PubMed ID: 2685657 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Greenlee JE; Brashear HR Ann Neurol; 1983 Dec; 14(6):609-13. PubMed ID: 6360029 [TBL] [Abstract][Full Text] [Related]
5. Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration. Greenlee JE; Lipton HL Ann Neurol; 1986 Jan; 19(1):82-5. PubMed ID: 3004320 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes. Smith JL; Finley JC; Lennon VA J Neuroimmunol; 1988 Apr; 18(1):37-48. PubMed ID: 3346369 [TBL] [Abstract][Full Text] [Related]
7. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Jaeckle KA; Graus F; Houghton A; Cardon-Cardo C; Nielsen SL; Posner JB Ann Neurol; 1985 Nov; 18(5):592-600. PubMed ID: 2416270 [TBL] [Abstract][Full Text] [Related]
8. Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Greenlee JE; Burns JB; Rose JW; Jaeckle KA; Clawson S Acta Neuropathol; 1995; 89(4):341-5. PubMed ID: 7610765 [TBL] [Abstract][Full Text] [Related]
9. Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein. Sakai K; Gofuku M; Kitagawa Y; Ogasawara T; Hirose G J Neuroimmunol; 1995 Jul; 60(1-2):135-41. PubMed ID: 7642741 [TBL] [Abstract][Full Text] [Related]
10. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452 [TBL] [Abstract][Full Text] [Related]
11. Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro. Greenlee JE; Parks TN; Jaeckle KA Neurology; 1993 Oct; 43(10):2049-54. PubMed ID: 8413965 [TBL] [Abstract][Full Text] [Related]
13. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration. Anderson NE; Budde-Steffen C; Wiley RG; Thurman L; Rosenblum MK; Nadeau SE; Posner JB Neurology; 1988 Jul; 38(7):1018-26. PubMed ID: 3290700 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia. Balegno S; Ceroni M; Corato M; Franciotta D; Giometto B; Marinu-Aktipu K; Nano R Anticancer Res; 2005; 25(5):3211-4. PubMed ID: 16101129 [TBL] [Abstract][Full Text] [Related]
15. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells. Rodriguez M; Truh LI; O'Neill BP; Lennon VA Neurology; 1988 Sep; 38(9):1380-6. PubMed ID: 3045692 [TBL] [Abstract][Full Text] [Related]
16. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. Meglic B; Graus F; Grad A J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295 [TBL] [Abstract][Full Text] [Related]
17. Demonstration of an epithelial antigen in colon by means of fluorescent antibodies from children with ulcerative colitis. BROBERGER O; PERLMANN P J Exp Med; 1962 Jan; 115(1):13-26. PubMed ID: 13873212 [TBL] [Abstract][Full Text] [Related]
19. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Dalmau J; Gultekin SH; Voltz R; Hoard R; DesChamps T; Balmaceda C; Batchelor T; Gerstner E; Eichen J; Frennier J; Posner JB; Rosenfeld MR Brain; 1999 Jan; 122 ( Pt 1)():27-39. PubMed ID: 10050892 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]